SELLAS Life Sciences Group, Inc. — Director's Dealing 2020

Mar 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELLAS Life Sciences Group, Inc. (SLS)
CIK: 0001390478
Period of Report: 2020-03-12

Reporting Person: Wasman Jane (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-12	Stock Option (Right to Buy)	$1.89	A	6500	Acquired	2030-03-12	Common Stock (6500)	Direct

Footnotes

F1: The shares subject to the option will fully vest on the earlier of (x) March 12, 2021 (the first anniversary of the date of grant) or (y) the business day prior to the 2021 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.